Stacking it with another GLP-1 agonist like semaglutide would be redundant and increase side effects without proportional benefit
Its powerful antioxidants also provide anti-aging benefits, leaving you with a rejuvenated and radiant complexion
Operating margin expanded to 49% in Q1 2026, up from 43% in Q1 2025, continuing a multi-quarter expansion arc that began at 38% in Q2 2024
Investigating the same primary endpoint, TRANSCEND-T2D-2 (NCT06260722) will compare retatrutide to semaglutide in people with inadequately controlled T2D (treated with oral glucose-lowering treatments) over 26 months
If you are considering GLP-1 treatment partly for off-label neuropsychiatric effects, genetic insights combined with provider guidance can help clarify whether this approach aligns with your biology and reduce trial-and-error adjustment
Bridge, Glutamate cysteine ligase and the age-related decline in cellular glutathione: The therapeutic potential of -glutamylcysteine